The aim of the present study was to evaluate the clinical and radiological effectiveness of transcrestal sinus elevation and simultaneous implant placement using osseodensification (OD) and crestal approach sinus (CAS) instruments.
This randomized controlled double-blinded clinical trial included 20 participants with edentulous spaces requiring 20 implants having residual bone height >5 mm in the posterior maxilla. Participants were randomly allocated into the CAS group and OD group. Indirect sinus elevation with simultaneous implant placement was performed in both groups. Implant stability (IS) was evaluated at baseline and 3 months. Crestal bone loss (CBL) was measured at 3, 6, and 12 months. Apical bone gain (ABG) was measured at 6 and 12 months. Surgical time and patient comfort using the Visual Analog Scale were assessed during the surgery. Unpaired
Sinus elevation and simultaneous implant placement showed good clinical and radiological outcomes in both groups. Intergroup comparison showed a significantly greater primary and secondary IS (
Both CAS and OD groups showed significant improvement in all parameters. OD group showed greater benefits in terms of enhanced primary stability, less CBL, enhanced ABG, and lesser surgical time compared to the CAS group.
Dental implants are a potential modality for prosthetic replacement due to their high success rates and functional effectiveness in sites with adequate bone volume and density for implant biointegration.[
The Crestal Approach Sinus kit (CAS-KIT) was created specifically to elevate the maxillary sinus membrane transcrestally safely. The CAS-Drill is a vital part of the CAS-KIT because it improves the simplicity and safety of maxillary sinus surgery by raising the membrane using a special stopper system to stop over-drilling into the sinus cavity.[
A relatively new method for biomechanically preparing bone is osseodensification (OD). With a fluted densifying bur during the operation, rolling and sliding contact generates modest plastic deformation of bone, densifying the bone without heat elevation developed by Huwais
Evidence supporting the use of OD in TISE is extremely scant. In order to assess and compare the clinical and radiological outcomes of TISE and simultaneous implant placement using OD and CAS instrumentation, the current randomized, prospective, and clinical trial was designed. The null hypothesis of the study was “there will be no significant difference in clinical and radiological outcomes between the two methods (OD and CAS) for transcrestal sinus elevation and implant placement.”
All participants were selected from the outpatient pool of the Department of Periodontics and Implantology at Vishnu Dental College, Bhimavaram. The study was approved and ethical clearance was obtained from the Institutional ethical committee with Ref No: IEC VDC/2021/PG01/PI/IVV/14 and approved under Clinical Trials Registry-India (CTRI/2021/07/034791). The study was conducted following the Helsinki Declaration as revised in 2013. Written informed consent was obtained from all the participants. The entire study period was from March 2021 to December 2022.
Twenty participants between ages 25 and 50 years with maxillary posterior edentulous sites and RBH of 4–7 mm were included. Eighteen participants had single posterior edentulous sites. Two participants had two missing adjacent posterior teeth in the maxilla. However, in participants having multiple adjacent missing teeth a single posterior-most implant was included in the trial. Exclusion criteria were participants with active sinusitis/inflammation, undergoing radiation therapy, uncontrolled systemic diseases, severe clenching or grinding habits, poor oral hygiene maintenance, smokers, pregnant/nursing women, and those with tumors/pathologic growths in the sinus.
Clinical and radiological baseline examinations were performed on all the individuals. The CONSORT guidelines were followed for allocating patients [
Consort flow chart.
Crestal approach sinus Group, (a) Preoperative occlusal view of implant site, (b) Implant placement done irt 25, (c) implant stability quotient (ISQ) of 83 immediately after implant placement, (d) simple interrupted sutures placed, (e) 1 week postoperative evaluation of implant site and suture removal, (f) Slit incision with placement of healing abutment at 3 months, (g) ISQ of 85 at 3 months postimplant placement, (h) 3 weeks evaluation of implant site after placement of healing abutment, (i) Implant site restoration with screw retained.
Osseodensification group: (a) Preoperative occlusal view of the implant site, (b) Flap elevation and osteotomy site, (c) Implant placement done irt 25,26, (d) implant stability quotient (ISQ) of 85 immediately after implant placement, (e) Simple interrupted sutures placed, (f) 1-week postoperative evaluation, (g) Flap elevation with insertion of healing abutments, (h) ISQ of 86 at 3 months postoperative, (i) Implant site restoration with screw-retained prosthesis.
Clinical and radiological parameters i.e., implant stability (IS), crestal bone loss (CBL), apical bone gain (ABG), surgical time, and patient comfort, were recorded. A radiofrequency analyzer (RFA) (Penguin™) was used to test the clinical stability of implants both immediately and 3 months after implant placement. The apical implant thread and coronal bone-to-implant contact were used as reference points to measure CBL on the mesial and distal sides of the implant that were parallel to the axis of the implant. A decrease in the vertical distance between the reference points postoperatively indicates the loss of crestal bone.[
G*power software version 3.1.9.7 (Heinrich-Heine-Universität Düsseldorf, Germany) was used to calculate the sample size. A total sample size of 14 was obtained with the power of the study set at 80% and an alpha value of 0.05 with an effect size of 1.74 taking into account ABG as the primary outcome variable based on previous studies. Considering the 20% dropout rate, the sample size was rounded to 20 (10 in each group).
Periapical radiographs were acquired using the paralleling cone technique using acrylic stent. Using a metal grid with a 1-mm measurement box, the vertical bone height was calculated from the alveolar bone crest to the sinus floor lining.
Local anesthesia, i.e., 2% lignocaine with 1:200,000 adrenaline was given. Full-thickness mucoperiosteal flap was elevated after a mid-crestal incision. Twenty milliliters blood was drawn from the patient’s cephalic vein and transferred to 10 mL blood collection tubes and immediately spun for 12 min at a speed of 1500 rpm in a table-top centrifuge.[
The osteotomy was prepared with a point (guide) drill. An appropriate S-reamer drill was then selected, which is 1 mm shorter than the expected bone height for safety and increased sequentially in each phase using a 1-mm long stopper. Based on implant diameter and insertion depth in the sinus, the S-reamer’s diameter was taken into account. Use the sinus membrane elevator drill to carefully elevate the sinus membrane. Continue to elevate the membrane until the desired height is achieved.
Initial preparation was done up to 2 mm deep using a pilot drill. After evaluating the radiographs, the OD osteotomy preparation was carried out using OD drills (Densah™). The smallest diameter drill (2.0) was chosen and used in an anticlockwise direction at 1200 rpm with bouncing irrigation until the sinus floor was reached. The sinus membrane was advanced in 1 mm increments using the succeeding larger diameter drills (3.3, 3.8 mm). After perforation of the inferior cortical wall was felt sinus elevation was done using the sinus membrane elevator drill until the desired sinus elevation was achieved. The RBH was determined using a depth gauge.
The Valsalva maneuver was used to make sure the membrane was intact and the A-PRF membrane was inserted. 4.2 mm × 10 mm implants (ADIN, TouaregTM-S), with internal hex connections and spiral tap designs, were placed equicrestally in all the participants. In both groups, the apical-coronal position of the implant shoulder was standardized by placing the implants at the level of the crest of the alveolar bone [
Participants were asked not to brush in the surgical area. Analgesics (Diclofenac 50 mg twice daily for 3 days) and antibiotics (Amoxicillin + clavulunate 625 mg three times daily for 3 days) were administered. Patients were advised mouth rinsing with 0.2% chlorhexidine gluconate twice daily for 15 days. Patients were reassessed for healing after a week, and the sutures were removed [
Second-stage surgery was done after a 3-month healing period allowing for implant osseointegration. The implant was exposed using a slit incision and the cover screw was removed. IS was analyzed using RFA [
Immediately following implant placement and 3 months later, IS was clinically evaluated [
Crestal approach sinus group radiographs at (a) 3 months, (b) 6 months and (c) 12 months after implant placement.
Osseodensification group radiographs at (a) 3 months, (b) 6 months and (c) 12 months after implant placement.
The data were statistically analyzed using the Statistical Package for the Social Sciences (SPSS) 21.0 version (IBM, Armonk, New York, United States). Unpaired
The age of the subjects ranged from 25 to 60 years, with a mean age of 52 in the CAS group and 47.50 in the OD group [
Distribution of age in the study groups
Distribution of males and females and implant sites in the study groups
The mean implant stability quotient (ISQ) values increased from 72.20 ± 4.56 to 75.50 ± 3.65 in the CAS group at 3 months which was statistically not significant (
Intragroup comparison of implant stability, crestal bone loss, and apical bone gain
Intragroup comparison of mean CBL on the mesial and distal sides in the CAS group from 3 to 12 months was highly statistically significant (
Crestal approach sinus Group-Crestal bone loss at (a) 3 months, (b) 6 months (c) 12 months, Apical bone gain at (d) 3 months, (e) 6 months (f) 12 months.
Osseodensification Group-Crestal bone loss at (a) 3 months, (b) 6 months, and (c) 12 months, Apical bone gain at (d) 3 months, (e) 6 months, and (f) 12 months.
Intergroup comparison of CBL on the mesial side at 3 and 6 months between the CAS group and OD group showed a significant difference (
Intergroup comparison of implant stability, crestal bone loss, and apical bone gain
The mean RBH in the CAS group on the mesial side was 6.99 mm, and on the distal side, 6.09 mm. Intragroup comparison in the CAS group showed statistically significant (
Intergroup comparisons of ABG between the CAS and OD groups from baseline to 6 months and baseline to 12 months showed a statistically significant mean increase from baseline, with the OD group showing considerably greater ABG than the CAS group.(
The average surgical time taken was 87.00 ± 15.49 min in the CAS group and 69.00 ± 20.24 min in the OD group with significantly less time in the OD group (
Intergroup comparison of surgical time and patient comfort
The TISE in both CAS and OD groups was uneventful with no peri-operative or postoperative complications reported. After 1 year of follow-up, both groups showed good survival rates. In TISE without augmentation, the important determinant of implant success is achieving good primary stability. On intergroup comparison, the mean ISQ values are greater for the OD group immediately after implant placement than CAS group. The significantly better primary stability in the OD group is in accordance with the studies done by Elghobashy
At 3 months postoperatively, in both groups, mean ISQ values increased indicating an improvement in the bone-to-implant contact. The mean secondary stability values were considerably greater for the OD group. The results are in accordance with Arafat and Elbaz, (75.92 ± 2.94) and Hamdi and Hemd (71.8 ± 5.5), who have reported greater secondary stability in the OD group.[
Rawat
The present study showed the most significant ABG in the OD group which is in accordance with a study by Arafat and Elbaz, where he reported an ABG of 2.79 mm in the osteotome group and 3.33 mm in the OD group.[
Surgical time was less for the OD group (69.00 ± 20.24) compared to the CAS group (87.00 ± 15.49), which is statistically significant. A study by Ibrahim
The mean patient comfort (VAS) scores obtained in the present study were 8.6, and 8.5 in the CAS and OD groups, respectively. In a study by Ibrahim
The current study showed that TISE and simultaneous implant placement using both the CAS and OD techniques are reliable, with good survival rates and can be used for implant placement in the atrophic posterior maxilla. However, the OD group showed slightly improved clinical and radiographic outcomes, which need to be assessed further with long-term trials to evaluate the success of implants placed.
In the present study, mean RBH in both groups was ≥6 mm. Further studies with less RBH could better evaluate the efficacy of the drills. Although good survival rates and clinical outcomes were obtained, a larger sample size and more extended follow-up periods are required to assess the definitive results of both interventions.
Both CAS kit and OD burs are effective in the safe elevation of the sinus membrane transcrestally with minimal or no complications. The results of the present study favor the OD group in terms of greater implant primary, secondary stability, and minimal CBL. ABG with reduced operating time compared to the CAS group. However, in both groups, patients were comfortable during the entire procedure.
TISE using the OD technique can be an effective and reliable alternative to conventional osteotomy preparation.
Nil.
The authors of this manuscript declare that they have no conflicts of interest, real or perceived, financial or non-financial in this article.